Please consult your physician to find out what is best for you and your treatment. Research is still very active in this area, and your healthcare provider will have the most up-to-date information for you. Currently, the only treatments approved by the FDA are “infection prevention and control measures and supportive care, including supplemental oxygen and mechanical ventilatory support when indicated”.
According to NIAID Director Anthony S. Fauci, M.D., “We urgently need a safe and effective treatment for COVID-19. Repurposing existing drugs is an attractive option because these medications have undergone extensive testing, allowing them to move quickly into clinical trials and accelerating their potential approval for COVID-19 treatment. Although there is anecdotal evidence that hydroxychloroquine (HCQ) and azithromycin may benefit people with COVID-19, we need solid data from a large randomized, controlled clinical trial to determine whether this experimental treatment is safe and can improve clinical outcomes.”
To learn more, the National Institute of Health (NIH) is beginning a clinical trial that hopes to understand whether HCQ and azithromycin truly are effective or if the treatment is no better than a placebo. This study is also aimed at determining what risks are involved when treating COVID-19 patients with these medications.